Preliminary Results From a Phase I/II Study of Fludarabine, Rituximab, and Lenalidomide In Untreated Patients with Chronic Lymphocytic Leukemia (CLL)
暂无分享,去创建一个
I. Flinn | J. Hainsworth | H. Burris | N. Dickson | J. Berdeja | K. Shih | H. Doss | J. Waselenko | J. Bi | R. S. Cooper | Dana S. Thompson